#USA #Boston #Ginkgo Bioworks #Araceli Biosciences #Endeavor Imaging

Introduction

In a significant advancement within the biotech industry, Araceli Biosciences and Ginkgo Bioworks have joined forces to integrate Araceli's Endeavor® high-content cellular imaging instrument into Ginkgo's autonomous lab, Nebula. This collaboration marks a pivotal shift in drug discovery, enabling researchers to generate large, curated datasets for training and validating AI models in drug discovery at an unprecedented scale.

The Endeavor® Imaging Instrument

The Endeavor® is hailed as the fastest high-content imaging system currently available, capable of imaging a 1536-well plate in under four minutes. This instrument is now part of Nebula's Reconfigurable Automation Cart (RAC) system, which combines robotic arms and automated sample transport to streamline workflows. With its continuous, real-time data generation capabilities, the Endeavor enhances Nebula's already impressive operations, allowing for simultaneous experimentation and rapid data analysis.

Real-Time Analysis and Quality Control

Using Araceli's proprietary ClaireRT™ software, the Endeavor processes images in real-time as they are captured. This means that should any well's data fall outside pre-defined criteria, the system can either alert lab operators or halt imaging altogether, ensuring quality control before proceeding with further experiments. This level of interactivity and adaptation marks a significant improvement for laboratories that traditionally rely on manual data analysis.

Enhancing Drug Discovery with AI

Matt Beaudet, President and CEO of Araceli Biosciences, emphasized the growing need for a more substantial volume of biological data in the development of next-generation AI for drug discovery. He noted that with instruments such as the Endeavor, labs can now create, interpret, and respond to cellular data in real-time, fundamentally transforming the research process.

Jason Kelly, co-founder and CEO of Ginkgo Bioworks, echoed this sentiment, highlighting the value of integrating top-notch instruments into autonomous labs. The combination of robust tools and continuous access to high-quality imaging allows scientists to work more efficiently and effectively, bolstering the research quality significantly.

The Autonomy of Nebula

Ginkgo's Nebula lab takes automation to the next level. Each of its 100+ RACs operates continuously, performing real research and generating data around the clock. With a smaller footprint than traditional lab setups, Nebula can cater to the same volume of research, effectively doubling productivity while reducing space requirements.

This integration represents a remarkable achievement in laboratory automation and robotics, setting a new standard for how research can be conducted, evaluated, and employed in real-time.

About the Companies

Araceli Biosciences

Araceli Biosciences focuses on developing cutting-edge high-content imaging instruments alongside AI-powered software tailored for automated laboratories. Their technology offers real-time insights into cellular activities, optimizing the workflow in biotech and pharmaceutical settings and enabling faster and more reliable drug discovery processes.

Ginkgo Bioworks

On the other hand, Ginkgo Bioworks seeks to democratize biology through its autonomy-driven laboratory solutions, replacing tedious manual tasks with robotic automation. Beyond enhancing scientific productivity, their approach has the potential to disrupt various industries by offering accessible biological engineering solutions, from pharmaceuticals to agricultural applications.

Conclusion

The collaboration between Araceli Biosciences and Ginkgo Bioworks is a game changer for cellular imaging and drug discovery. As lab operations become increasingly reliant on automation and advanced imaging technologies, this partnership's impact will resonate through the biotech industry's evolving landscape. Fueled by innovation, the future of drug discovery appears brighter than ever.